Zydus receives final approval from the USFDA for Acyclovir Capsules USP
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated March 29, 2016 titled "Zydus receives final approval from the USFDA for Acyclovir Capsules USP". Zydus acquires the gastro therapy 'Actibile from Albert David Limited, Strengthens its presence in the gastroenterology segment
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated March 28, 2016 titled "Zydus acquires the gastro therapy 'Actibile from Albert David Limited, Strengthens its presence in the gastroenterology segment".
Cadila gets WHO warning for its Moraiya vaccine plant in Gujarat
The world body, in its inspection from 26-30 October, found data integrity issues at the plant that manufactures Lyssavac-N, an anti-rabies vaccine Clarification
Cadila Healthcare Ltd has informed BSE that:"There have been some reports regarding the pre-qualification plant inspection of the vaccines facility by WHO in terms of the possible linkage with our oral solids and injectable facilities at the Moraiya manufacturing complex.In this regard, we hereby inform that we have a separate manufacturing facility for vaccines and this does not form a part of the oral solids and injectable facilities... Cadila Healthcare: The right remedy - Buy
The large pipeline of drugs awaiting regulatory nod should boost revenues Zydus Cadila gets US FDA nod to market Clofarabine Injection
Healthcare player Zydus Cadila (Cadila Healthcare Limited) on Wednesday announced that the company has received the tentative approval from the US Drug Regulator, USFDA to market its Clofarabine Inje... Zydus receives tentative approval from the USFDA for Clofarabine Injection
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated March 09, 2016 titled "Zydus receives tentative approval from the USFDA for Clofarabine Injection". Fixes Record Date for Interim Dividend
Cadila Healthcare Ltd has informed BSE that the Company has fixed March 18, 2016 as the Record Date for the purpose of Payment of Interim Dividend.Further, the interim dividend shall be paid to the members entitled thereto, on and from March 23, 2016. The Dividend cheques would be posted on or after March 23, 2016 and within 30 days from the date of declaration of dividend as provided in the Companies Act, 2013. Board declares Interim Dividend
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 08, 2016, has declared an interim dividend of Rs. 3.20/- [i.e. @ of 320%] per Equity Share on 102,37,42,600 Equity Shares of Rs. 1/- each of the Company for the financial year 2015-2016. Board to consider Interim Dividend
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 08, 2016, inter alia, to consider, declaration of Interim Dividend for the financial year 2015-16 and to fix the Record date.Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from March...